Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2020-10-15
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim of this study is to assess agreement and repeatability of epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
Secondary objective is to evaluate the differences between healthy and keratoconus eyes using epithelial thickness map data.
This is a prospective monocentric study that includes patients divided into two groups: patients with keratoconus and a control group formed out of patients without corneal pathologies. For each patient only one eye will be included and corneal measurements will be performed, focused on the corneal epithelium thickness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution OCT
NCT03184610
Evaluation of the Accuracy of Corneal Epithelial Thickness Mapping With SD-OCT
NCT02775097
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT
NCT02781948
Evaluation of Corneal Epithelial Thickness Mapping
NCT01712022
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT
NCT02600546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation. After each measurement patients will be asked to blink in order to allow adequate tear-film recovery. Each patient will be measured three times with both devices. Only one visit will be necessary.
The order in which the measurements will be performed (Anterion or MS-39) will be randomised using randomised.org.
The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
Main outcome variable:
\- Mean differences in central corneal epithelial thickness between the devices investigated (+ limits of agreement (1.96xSD) between the investigated devices)
Secondary outcome variables:
* Repeatability coefficient (within subject standard deviation - SD) and coefficient of variation of the two devices
* Comparison in epithelial thickness between normal and keratoconus eyes
* Sensitivity and specificity of swept-source OCT device in keratoconus diagnosis
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epithelial thickness map evaluation in keratoconus patients
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
Corneal epithelial thickness measurements
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
Epithelial thickness map evaluation in healthy cornea patients
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
Corneal epithelial thickness measurements
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Corneal epithelial thickness measurements
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 21 and older
* Signed informed consent
Exclusion Criteria
* Associated corneal pathologies (e.g. trauma, edema, scarring)
* In women of childbearing age, a pregnancy test will be performed before inclusion into the study.
21 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Head of Department of Ophthalmology, Professor, Principal Investigator, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, Prof., MD
Role: PRINCIPAL_INVESTIGATOR
Head of Department of Ophthalmology, Professor, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanusch Hospital, Ophthalmology Department
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Epithelial thickness map
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.